Stockscreener 앱 받기
6.78
3.28%
-0.23
CorMedix Inc 주식(CRMD)의 최신 뉴스
Sentiment Review: Whats the profit margin of PGHLPortfolio Gains Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
CorMedix (CRMD) Is Down 11.1% After CEO Becomes Chair And Sets 2026 Revenue TargetHas The Bull Case Changed? - simplywall.st
CorMedix (CRMD) price target decreased by 11.28% to 17.19 - MSN
Breaking Update: Steven Lefkowitz Engages In Options Exercise At Cormedix Realizing $22K - Benzinga
Will DefenCath Continue to Aid CorMedix's Top Line in Q4 Earnings? - Yahoo Finance
Weekly Recap: Is CorMedix Inc benefiting from interest rate changesJuly 2025 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Death Cross: Can CorMedix Inc stock deliver 10 annual returnsPortfolio Performance Summary & Daily Chart Pattern Signal Reports - Bộ Nội Vụ
CorMedix (NASDAQ:CRMD) Shareholders Are Still up 63% Over 3 Years Despite Pulling Back 37% in the Past Week - 富途牛牛
CorMedix (CRMD) Valuation After New Leadership Moves And 2026 Revenue Guidance - Sahm
Why Did CRMD Stock Crash 28% Today? - Asianet Newsable
CRMD: 2026 will be a transitional year, with growth driven by new indications and pipeline catalysts - TradingView — Track All Markets
CorMedix stock price target lowered to $15 by Leerink Partners By Investing.com - Investing.com India
CorMedix stock price target lowered to $15 by Leerink Partners - Investing.com Nigeria
CorMedix: The Post-TDAPA Hangover Arrived Early (Rating Downgrade) (NASDAQ:CRMD) - Seeking Alpha
How sustainable is CorMedix Inc. stock dividend payoutWeekly Trading Summary & Precise Buy Zone Identification - Улправда
Asset turnover of CorMedix Inc. – HAM:19KA - TradingView — Track All Markets
CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Revenue Outlook And Reshuffling Leadership - simplywall.st
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations - The Globe and Mail
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge (CRMD) - Seeking Alpha
Are Investors Undervaluing CorMedix (CRMD) Right Now? - Yahoo Finance
CorMedix Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story - Yahoo Finance
Why CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Guidance And Revamping Its Leadership Structure - Yahoo Finance
Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Sahm
CorMedix stock rises after-hours: CEO locks in chairman seat, bigger paycheck and rich severance - MSN
CorMedix Stock Rises After-Hours: CEO Locks In Chairman Seat, Bigger Paycheck And Rich Severance - Stocktwits
CorMedix Inc.Common Stock (NQ: CRMD - FinancialContent
What sentiment indicators say about CorMedix Inc. stockJuly 2025 Levels & Technical Confirmation Alerts - ulpravda.ru
Truist Securities lowers CorMedix stock price target on weaker revenue outlook By Investing.com - Investing.com South Africa
Breakout Move: Will CorMedix Inc. stock maintain growth storyDay Trade & Growth Focused Investment Plans - ulpravda.ru
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes - Yahoo Finance
Why is CorMedix stock crashing today: is it worth buying on the dip? - CryptoRank
Truist Securities lowers CorMedix stock price target on weaker revenue outlook - Investing.com Australia
CorMedix Therapeutics Appoints Joseph Todisco as Chairman, Extends CEO Contract - citybiz
CorMedix shares fall as 2026 revenue outlook disappoints (update) - MSN
Cormedix: Market Overreaction to 2026 Guidance Creates Undervalued Buy Opportunity - TipRanks
Alibaba, Costco among market cap stock movers on Thursday - Investing.com
Why CorMedix stock crashed today and is it worth buying on the dip? - Invezz
Is CorMedix Inc. stock a top pick in earnings seasonJuly 2025 Analyst Calls & Stock Portfolio Risk Management - ulpravda.ru
CorMedix price target lowered to $16 from $20 at Truist - TipRanks
Will CorMedix Inc. stock maintain growth storyQuarterly Trade Report & Smart Money Movement Alerts - ulpravda.ru
CorMedix Inc. Stock (CRMD) Opinions on 2026 Revenue Guidance - Quiver Quantitative
ELVN Stock Shot Up 60% Today – What’s Driving The Rally? - Stocktwits
Is CorMedix Inc. (19KA) stock resilient in recession scenariosLong Setup & Safe Capital Investment Plans - ulpravda.ru
CorMedix shares slip after unveiling lower revenue outlook for 2026 - MSN
GLUE Stock Up 45% on Positive Interim Data on Inflammation Drug - The Globe and Mail
CEO Moves: Is CorMedix Inc. (19KA) stock resilient in recession scenariosJuly 2025 Macro Moves & Verified Swing Trading Watchlist - ulpravda.ru
CorMedix Inc. Provides Earnings Guidance for the Year 2026 - MarketScreener
CorMedix sees FY26 revenue $300M-$320M - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance By Investing.com - Investing.com South Africa
Cormedix Issues Strong Preliminary Q4 Results, Updates Outlook - TipRanks
Cormedix Therapeutics announces preliminary fourth quarter and full year 2025 results - marketscreener.com
CorMedix sees Q4 revenue $127M, consensus $127.52M - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance - Investing.com
Cormedix Therapeutics Announces Preliminary Fourth Quarter And Full Year 2025 Results - TradingView — Track All Markets
CorMedix announces leadership changes with CEO taking chairman role By Investing.com - Investing.com India
(CRMD) CorMedix Expects 2026 Revenue Range $300M to $320M, vs. FactSet Est of $435.7 - marketscreener.com
CorMedix reports $127 million Q4 revenue, provides 2026 outlook - Investing.com
4.73%
0.92%
자본화:
|
볼륨(24시간):